Company Financials: Orthopaedics and Spine

• Posted in Business Critical | June 09, 2012 | Comments (0)
• Tags: financial, company financials, sales
• By: Julie A. Vetalice

ORTHOWORLD’s estimates place overall 2011 market growth at 4% over 2010, as displayed in Exhibit 1. Performance highlights follow and pertain to both 4Q11 and 2011, as indicated. 

Exhibit 1: Orthopaedic Sales Increases¹ by Product Segment: 2011 vs. 2010

Notes to Exhibit 1

1. Orthopaedic products except as indicated; constant currency, pro forma growth
2. Includes biologics
3. For the quarter ended 11/30/11; includes Dental. Spine includes Bone Stim and Biologics; Bone Stim reflects all Bone Healing sales.
4. For the quarter ended 1/27/12
5. Spine
6. For the quarter ended 12/31/11
7. Extremities: extremities + fixation combined; Endoscopy: endoscopic + communications, most of which is orthopaedic; Spine: neuro + spine. Total growth excludes Patient Handling.
8. ORTHOWORLD estimates
9. For the quarter ended 12/31/11
10. Excludes Other (Aerospace)